Pharmacy News Article

4 November 2009 - France-based Alcatel-Lucent (EPA: ALU) said today that the US Food and Drug Administration (FDA) has cleared for marketing its remote patient monitoring solution, the Alcatel-Lucent TeleHealth Manager.

The product supports remote patient monitoring with an easily deployable solution for standard mobile phones from leading vendors. It allows patients to provide health data using devices they are already familiar with (e.g., mobile phones and medical devices such as blood glucose meters), the company said. In addition to monitoring, TeleHealth Manager provides reminders, alerts and online reports to help patients and their healthcare professionals better understand and manage their conditions.

((Comments on this story may be sent to tww.feedback@m2.com))